🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Ovarii › Wisconsin › Madison

Qorannoo klinikaalii Kansarii Ovarii Madison, WI keessatti

Qorannoo 13 Kansarii Ovarii f Madison fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Namoota walitti qabaa jiraSadarkaa 2/3
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Namoota walitti qabaa jiraSadarkaa 2
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Umuriin hundi · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Wisconsin Carbone Cancer Center, Madison
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Namoota walitti qabaa jiraSadarkaa 2
  • UW Health Carbone Cancer Center, Madison
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06760819

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Namoota walitti qabaa jiraSadarkaa 2
  • Research Site, Madison
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05489211

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • University of Wisconsin - Carbone Cancer Center, Madison
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07213791

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • University of Wisconsin, Madison
Umuriin 18 fi ol · Dubartoota · Haaromfame 14-Ful-2026 · NCT06787612

Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers

Namoota walitti qabaa jiraQorannoo ilaalaa
  • UW Carbone Cancer Center, Madison
Umuriin 18 fi ol · Dubartoota · Haaromfame 27-Hag-2026 · NCT07125209

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Namoota walitti qabaa jira
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Umuriin 35 hanga 50 · Dubartoota · Haaromfame 07-Hag-2026 · NCT04251052

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

Namoota walitti qabaa jiraSadarkaa 2
  • University of Wisconsin - Carbone Cancer Center - University Hospital, Madison
Umuriin 18 hanga 100 · Dubartoota · Haaromfame 13-Ado-2026 · NCT05887609

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Wisconsin, Madison
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT06710756

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

Namoota walitti qabaa jiraSadarkaa 1
  • University of Wisconsin Carbone Cancer Center, Madison
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Wax-2026 · NCT05568680

Qorannoo Kansarii Ovarii magaalota biroo keessatti

Qorannoo biroo Madison keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.